Multidrug-Resistant Tuberculosis and Extensively Drug-Resistant Tuberculosis

Seung, Kwonjune J., Keshavjee, Salmaan, Rich, Michael L.·2015·Cold Spring Harbor Perspectives in Medicine
DOI 10.1101/cshperspect.a017863

Cited by (803)

Items 601–700 of 803

  1. Multidrug-Resistant Tuberculosis (MDR-TB): Epidemiology, Causes, Pathophysiology, Diagnostic Approaches, Preventive Interventions, and Treatment Challenges/Opportunities – (An Evidence-Based Narrative Literature Review)
    Khalid Rahman · 2019 · TEXILA INTERNATIONAL JOURNAL OF CLINICAL RESEARCH
  2. New Insights into Mycofactocin Biosynthesis, Structure and Function
    Richard S. Ayikpoe · 2019 · Digital Commons - DU (University of Denver)
  3. Chest manifestations of human immunodeficiency syndrome: A study from central Karnataka
    Karnappa Bhangari, Basavaraj Sureshbabu Sangolli · 2020 · IP Indian Journal of Immunology and Respiratory Medicine
  4. Changing Pattern of Tuberculosis: Clinical Presentation Within a Decade - Analysis from South-East Europe
    Matea Škoro, Marija Alilović, Marina Lampalo, Matea Škoro, Sanja Popović Grle, Vesna Trkeš · 2020 · Gerontology and Geriatric Research
  5. A Review on Current Trends of Anti-Tubercular Drugs and Challenges in Eliminating Tuberculosis
    Ashish Akshay Bedi, Kaivalya R Pillai, Pankhuri Jain, Hashim Khan · 2020 · International Journal of Pharmacy and Pharmaceutical Research
  6. Is Rapid Molecular Testing enough In Screening Resistant Tuberculosis In Community
    Dhaker Ashok, B Ashish, Vishal Mangal, K Yadav Arun, Singhal Anuj, Gupta Anoushka · 2021 · medRxiv
  7. Primary Drug-Resistant Tuberculosis in the Elderly in Shandong,China,from 2004 - 2019.
    Qi-qi An, Wan-mei Song, Jinyue Liu, Ningning Tao, Yao Liu, Qian-yun Zhang, Tingting Xu, Shi-jin Li, Siqi Liu, Yifan Li et al. · 2020
  8. Prevalence and clinical characteristics of Diabetes in Tuberculosis patients in Newham
    Jalal Miah · 2020 · Sheffield Hallam University
  9. Shorter All-oral Bedaquiline-containing MDR-TB Regimen : The Backgrounds & Implementations
    Eden Suryoiman Winoto, Didi Candradikusuma · 2021 · Clinical and Research Journal in Internal Medicine
  10. Extra-Pulmonary TB
    Sarita Rani, Ankur Kaul, Anil Kumar Mishra, Umesh Dutta Gupta · 2021 · Advances in medical diagnosis, treatment, and care (AMDTC) book series
  11. The role of Lymphoblastic leukemia 1 (Lyl1) in Mycobacterium tuberculosis (Mtb) infection
    Shelby-Sara Jones · 2021 · Open University of Cape Town (University of Cape Town)
  12. Remodelling of Mycobacterial Peptidoglycan During Cell Division and the Epigenetics of Macrophages during M. tuberculosis infection
    Nathan Scott Kieswetter · 2021 · Open University of Cape Town (University of Cape Town)
  13. Assessment of Healthcare Providers Compliance with Standard of MDR TB Care and Treatment Outcome
    Laura Ifunanya Madukaji, Ebenezer Obi Daniel, Francis Enenche Ejeh, Adewole Olanisun Olufemi, Ahmed Mamuda Bello, Paul Olaiya Abiodun, Israel Olukayode Popoola, Kabir Yunusa Amari, Christiana Asibi-Ogben Inegbeboh, Oladapo Michael Olagbegi et al. · 2021 · World Journal of Public Health
  14. GM Crops: The West versus the Rest
    Jennifer Ann Thomson · 2021 · IntechOpen eBooks
  15. Dynamic model for simulating the acceptance problem of nuclear energy
    W. Seifritz, Johannes Mennig · 1987 · Transactions of the American Nuclear Society
  16. ANALYSIS OF TUBERCULOSIS DYNAMICAL MODEL WITH DIFFERENT EFFECTS OF TREATMENT
    Anindita Henindya Permatasari, Robertus Heri Soelistyo Utomo · 2021 · Journal of Fundamental Mathematics and Applications (JFMA)
  17. Diagnosis and Antimicrobial Susceptibility of Mycobacterium Tuberculosis in a Tertiary Care Hospital in Bangladesh
    Mostofa Showkat Imran · 2022 · Annals of International medical and Dental Research
  18. Empiric Addition of Quinolones to First-Line Tuberculosis Treatment Is Associated With Increased Odds of XDR-TB
    Zarir Udwadia, Palak P. Patel, Samridhi Sharma, Amita Gupta, Jeffrey A. Tornheim · 2022 · Frontiers in Tropical Diseases
  19. Chemical synthesis to tackle tuberculosis
    2022 · Research outreach
  20. Transferability of a EUnetHTA relative effectiveness assessment to low- and middle-income countries setting
    T. I. Armina Padmasawitri, Ahmad Fuady · 2022 · International Journal of Technology Assessment in Health Care
  21. THE EMERGING WORLD OF ANTIBIOTICS AND THE TERROR OF ANTIBIOTIC RESISTANT MICROORGANISMS: A REVIEW
    Leepakshi Dhingra, Pooja Singh, Angkita Sharma, Preeti Arivaradarajan, Shoma Paul Nandi · 2021 · International Journal of Environment and Health Sciences
  22. Role of GeneXpert MTB/RIF assay in detection of Mycobacterium tuberculosis in smear-negative sputum samples
    Enas Sh. Khater, Khalid H. M. Abdo · 2022 · Microbes and Infectious Diseases /Microbes and Infectious Diseases
  23. Combatting Drug-Resistant Tuberculosis in the Midst of the Ongoing COVID-19 Pandemic
    Tahmina Joy Rashid, Mainul Haque · 2022 · Advances in Human Biology
  24. Analysis of real-time PCR Melanocortin 3 (MC3R) gene expression to identify new biomarkers inflammation in tuberculosis
    Andi Tenriola, Najdah Hidayah, Subair, Muhammad Nasrum Massi, Handayani Halik, Tri Damayanti, Jafriati, Andi Tenri Ola Rivai · 2022 · Egyptian Journal of Medical Human Genetics
  25. AN INSIGHT INTO PRIVILEGED SCAFFOLDS IN TUBERCULOSIS: DEVELOPMENTAL ASPECTS AND IMPLICATIONS IN DRUG DESIGN
    Rani. A. Shinde, Vasanti Suvarna, Arundhati Nachiket Abhyankar · 2022 · INDIAN DRUGS
  26. Unilateral Choroidal Granuloma and a Pupillary Abnormality in a Case of Miliary Tuberculosis: A Dilemma for the Physician
    Vijaya Jojo, Poonam Singh, Rudra Prasad Samanta, Reyaz Ahmad · 2022 · Cureus
  27. Evaluation of AYC-SENSITIVE® for Rapid Detection of Multi-Drug Resistance and Extensively- Drug Resistance in Mycobacterium tuberculosis Isolates
    Kübra Yıldırım, Cemilenur Ataş, Ece Şimşek, Ahmet Yılmaz Çoban · 2022 · Research Square
  28. When is the use of suboptimal treatment in functionally untreatable multi-drug resistant tuberculosis morally permissible?
    Chavy Arora · 2022 · Global Public Health
  29. Quality of life in drug resistant tuberculosis
    Siddharth Chatterjee · 2022 · International Journal of Research in Medical Sciences
  30. Docking Studies of N-alkylated Indole Derivatives with Mycobacterium Enoyl Acyl Carrier Protein Reductase (Inh A) as Potent Antitubercular Agents
    Shivam Joshi, Neha Kawathekar · 2022 · Oriental Journal Of Chemistry
  31. Growth of pyridinecarbothioamides and single crystal XRD studies
    C. Revathi, O. Senthilkumar, S. Soundeswaran · 2022 · Materials Today Proceedings
  32. Recent applications of nanomedicine in lung disease
    Atul Kumar Srivastava, Mrinalini Kumari, Dinesh Prasad Gond, Subhashini · 2022 · Elsevier eBooks
  33. Caracterización de la tuberculosis multidrogorresistente y resistente a rifampicina en Colombia
    José Augusto Urrego Díaz, Julián Trujillo-Trujillo, Mónica Cárdenas, Óscar A. Cruz · 2022 · Revista de Salud Pública
  34. Extensively Drug Resistance Tuberculosis with Bedaquiline Toxicity: A 2-year Case Report
    Puvaneswari Kanagaraj, Anbueswari Kanagaraj · 2022 · Pondicherry Journal of Nursing
  35. Baseline Fluoroquinolone Resistance among MDR/RR –TB cases: A Retrospective Public Sector Hospital-based Study from Goa, India
    2022 · Journal of Medical Science And clinical Research
  36. Anti-Tuberculosis Therapy in The Drug Resistant Tuberculosis Patients of Kashmir Valley
    Aijaz Nabi Puttoo, Sandeep Tripathi, Naveed Nazir Shah, Ruqeya Nazir, Haamid Bashir, Aaliya Mohi-Ud-Din Azad, Rehana Kauser, Inam-Ul-Haq · 2022 · International Journal of Life Science and Pharma Research
  37. Pathogenesis of Human Immunodeficiency Virus and Mycobacterium tuberculosis Infection as Revealed by Transcriptome and Interactome Data
    Pooja Wakchoure, Khizra Momin, Abdul Arif Khan · 2023 · OMICS A Journal of Integrative Biology
  38. Control of Zoonotic TB: The Need for Multidisciplinary One Health Framework
    Adwoa Asante-Poku, Isaac Darko Otchere, Prince Philip Ankapong Asare, Stephen Osei-Wusu, Eric Koka, Dorothy Yeboah‐Manu · 2023 · Springer eBooks
  39. Hope toward potent drug target using tertiary topological instances of Mycobacterial transmembrane protein
    Mohd Asjad Baig · 2022 · Journal of Bacteriology & Mycology Open Access
  40. Nanosuspensions in Treatment of Tuberculosis
    Atul Garkal, Priyanka Bangar, Khushboo Mathur, Dhaivat C. Parikh, Tejal A Mehta · 2023 · Springer eBooks
  41. Antitubercular drugs
    AFZAL BASHA SHAIK, M. Mukhlesur Rahman · 2023 · Elsevier eBooks
  42. Database Morfologi dan Senyawa Mikrob sebagai Dataset Artificial Intelligence untuk Percepatan Pengembangan Obat Anti-infeksi dari Sumber Daya Mikrob Indonesia
    Danang Waluyo, Anis Herliyati Mahsunah, Dyah Noor Hidayati, Avi Nurul Oktaviani, Ariza Yandwiputra Besari, Kiki Rizkia Afrianti, Kristiningrum Kristiningrum, Suryani Suryani, Amila Pramisandi, Imam Civi Cartealy et al. · 2023 · Penerbit BRIN eBooks
  43. Missed phenotypic drug resistance in pediatric tuberculosis: A cause of concern in a resource-limited setting
    Bineeta Kashyap, Sapna Jhanjharia, Rituparna Saha, Sunil Gomber · 2023 · Indian Journal of Tuberculosis
  44. Cartridge-based nucleic acid amplification test in drug-resistant Mycobacterium tuberculosis as compared to solid cultures
    Ashok Dhakar, Anuj Singhal, Kiran Kumar Kompella, Arun Kumar Yadav, Vishal Mangal · 2023 · MRIMS Journal of Health Sciences
  45. Current Status of Drug Resistant Mycobacterium tuberculosis and the Value of Relevant Detection Techniques
    彧滔 雍 · 2023 · Advances in Clinical Medicine
  46. Expansion on the Use of the Novel Compound, ELP-004, Using a Mycobacterium tuberculosis Experimentation Model
    Kendyl Berry · 2023
  47. USO DE LINEZOLIDA NO TRATAMENTO DE TUBERCULOSE MULTIRRESISTENTE
    Diego Fellipe Santos Silva, Caique Pereira de Paiva, Suzana Bertanha, Tagstan Ribeiro Moioli, Ana Clara Godinho de Freitas, Rosângela Cristina de Souza Abdala, Isabella Elias Soares, Pedro Augusto Balista Canevarolo, Alexandre Teixeira do Amaral, Carollayne Mendonça Rocha · 2023 · RECIMA21 - Revista Científica Multidisciplinar
  48. Changing Trends in the Diagnosis of Genitourinary Tuberculosis in Post Covid-19 Pandemic Era
    Sriram Krishnamoorthy, Kalpana Ramachandran · 2023 · Medical Research Archives
  49. Molecular mechanism of Clofazimine resistance in tuberculosis
    Khatun Sumaia, Sadia Afrin, Alam Shah · 2023 · Journal of Infectious Diseases and Immunity
  50. A complementary approach to measure construct validity of WHO QOL BREF in Indian multidrug-resistant tuberculosis (MDR-TB) patients through psychometric property and factor analysis
    Shweta Sharma, Arun Mahadeo Kokane, Subba N. Krishna, Ankur Joshi · 2023 · F1000Research
  51. Machine learning and phylogenetic analysis allow for predicting antibiotic resistance in M. tuberculosis
    Alper Yurtseven, Sofia Buyanova, Amay Ajaykumar Agrawal, Olga Bochkareva, Olga V. Kalinina · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  52. “Knowledge, attitude and perception towards multi drug-resistant and extensively drug-resistant tuberculosis among health care professionals” – A cross sectional study
    Padmapriya Veeraragavan, Saranya Punniyakotti, Karthickeyan Krishnan · 2023 · AIP conference proceedings
  53. Reasons of TB Treatment Non Compliance
    Khawaja Ijaz Awais, M. Arslan Rasheed, Zoha Ejaz, Taj Jamshaid, Saim, Ahmad Latif · 2023 · Esculapio
  54. Genome Mining of Salinispora Uncovers a Repertoire of Secondary Metabolites and Carbohydrate-Active Enzymes
    Md. Saddam Hossain, Md Tarikul Islam, Md. Hadisur Rahman, Abdullah Al Zubaer, Abu Hashem · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  55. Favorable clinical outcomes and anti-mycobacterial efficacy of pretomanid in patients with highly resistant tuberculosis: A review
    Tanishq Joshi, Parminder Nain, Prajwal Bhamra, Jaspreet Kaur · 2023 · Indian Journal of Tuberculosis
  56. Current Prospects: Drug acting against resistant Tuberculosis
    Monika, Rakesh Yadav · 2023 · International Journal of Membrane Science and Technology
  57. Tuberculosis
    Sudipto Saha, Sreyashi Majumdar, Parthasarathi Bhattacharyya · 2023 · Springer eBooks
  58. ADME, Synthesis and Antimycobacterial Activity of 1,2,4-Triazol-3-thiol Linked Phenylacetamide Derivatives
    Trupti Sameer Chitre, Shivani Jadhav, Kalyani Dhirendra Asgaonkar, Kunal Pradhan, Kalash Shelke, Shubhangi Thorat, Aniket L. Bhatambrekar · 2023 · Current Indian Science
  59. Deep Insight to Mycobacterium Tuberculosis (Mtb): Causes, Symptoms, Diagnostics, Treatment, Risk Assessment & Recent Advances
    Sripathi Chandragupthan · 2023 · Journal of Medical Science And clinical Research
  60. Mycobacterium Tuberculosis Drug Resistance Mechanisms
    Santana Clarissa Cunha, Silva Camila Santos, Silva Paula Rocha Dantas, Mota Scarlet Torres Moraes, Theolis Barbosa, Duarte Tonya Azevedo · 2023 · Research and Reviews of Infectious Diseases
  61. DRUG RESISTANCE PATTERN OF MYCOBACTERIUM TUBERCULOSIS ISOLATED FROM PULMONARY AND EXTRA PULMONARY SAMPLES
    2023 · International Journal of Biology Pharmacy and Allied Sciences
  62. N-Unsubstituted 1,2-benzothiazine 1,1-dioxides: Pd-catalyzed one-pot sonochemical access and in silico / in vitro evaluation against MtbCM
    Narender Addu, Hinuja Miriyala, Ravikumar Kapavarapu, Sunder Kumar Kolli, Manojit Pal · 2023 · Journal of Molecular Structure
  63. Mesenchymal stem cells—role in tuberculosis pathogenesis and persistence
    Sapna Bajeli, Shweta Singh, Rajendra Singh Rajpurohit, Rinku Thakran, Sonal Datta, Ashwani Kumar · 2024 · Elsevier eBooks
  64. Design of Cyclobut-3-Ene-1,2 Dione Derivatives as Anti-tubercular Agents
    N. Ramalakshmi, K. Bhuvaneshwaran, A. Prabakaran, N.J. Thulasiraman, M. Bhavani, R. Aysvaryah, S. Arun-Kumar · 2024 · Current Enzyme Inhibition
  65. Tackling Infectious Diseases with Special Reference to India: Need for Multidimensional Approach
    Yasmeena Hassan, Ishfaq Majeed, Jahangir Mohi Uddin, Sadaf Saleem, Mohd Younis Rather, Ajaz Ahmad Waza · 2024 · Journal of Advances in Medicine and Medical Research
  66. Pangenome-wide association study reveals selective absence of CRISPR genes (Rv2816c-19c) in drug-resistant Mycobacterium tuberculosis
    Nikhil Bhalla, Ranjan Kumar Nanda · 2024 · medRxiv
  67. Navigating Foot Tuberculosis in a Leprosy Survivor: A Case Managed Solely With Medical Strategies
    Hardik Patel, Aditya Pundkar, Sandeep Kumar Shrivastava, Saksham Goyal, Rohan Chandanwale · 2024 · Cureus
  68. A retrospective assessment of rifampicin resistance in paediatric tuberculosis in a tertiary hospital in south west Nigeria
    Idemudia Imonikhe Otaigbe, Charles John Elikwu, T. O. Oluwole, A.E. Ogunlolu, O.E. Oseni, O.D. Bello, P.O. Olayiwola, V.C. Dike-Israel, G.J. Atuk · 2024 · Research Journal of Health Sciences
  69. Application of Data Mining in Pharmaceutical Research
    Zhenyu Pan, Limei Zhao, Deyong Jia, Jun Lyu, Shiyi Cao · 2024 · Frontiers research topics
  70. Impact of adverse drug reaction on quality of life in drug resistant tuberculosis
    Siddharth Chatterjee, Arvind Pandey · 2024 · International Journal of Research in Medical Sciences
  71. Baseline determinants of adherence for drug-sensitive TB treatment in a South African prospective cohort: a focus on HIV infection and anti-retroviral therapy, clinical care access, and TB stigma
    Adrian Steulet, Piotr Hippner, Noriah Maraba, Lauren Jennings, Israel Rabothata, Rachel Mukora, Nokhanyo Xaba, Lihle Mchunu, Kavindhran Velen, Catherine Orrell et al. · 2024 · Research Square
  72. Resistant Tuberculosis: A Comprehensive Health Predicament
    Susmita Sinha, Rahnuma Ahmad, Kona Chowdhury, Mainul Haque · 2024 · Bangladesh Journal of Medical Science
  73. Factors Influencing Knowledge on the Completion of Treatment among Tuberculosis Patients under Directly Observed Treatment Strategy (DOTS) in a Selected Health Facility, the Bahamas
    Daniel Esther S, Collie Latasha, Neymour Alice, Martin-Chen Nicole KA, Moss Kevin, Kathy-Ann Lootawan, Virginia M Victor · 2024 · Clinical Journal of Nursing Care and Practice
  74. ВПЛИВ ПАНДЕМІЇ COVID-19 НА ТЕНДЕНЦІЇ ВИЯВЛЕННЯ ХВОРИХ НА АКТИВНИЙ ТУБЕРКУЛЬОЗ
    Н. О. Теренда, М. М. Ружицький, І. Ю. Бевзюк, О. Н. Литвинова · 2024 · Вісник соціальної гігієни та організації охорони здоров я України
  75. Development of Scoring and Stratification of Severe Lung Involvement in Multidrug-Resistant Pulmonary Tuberculosis Patients
    Thungathurthi Smitha, Prabhakar Orsu, Sindgi Vasudeva Murthy · 2022 · Current Research in Tuberculosis
  76. One-day phenotypic drug susceptibility testing for Mycobacterium tuberculosis variant bovis BCG using single-cell imaging and a deep neural network
    Buu Minh Tran, Jimmy Larsson, Anastasia Grip, Praneeth Karempudi, Johan Elf · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  77. Rifampicin mono resistant tuberculosis (RR-TB): a case report
    Efyluk Garianto, Barkha Agung Priyanto, Benedictus Sebastian Aldorino, Berlian Rutana Pratiwi, Bima Aji Lazuardi, Bimo Saefulloh Fattah, Yohana Octavianda · 2024 · Surabaya Medical Journal
  78. Mechanisms and Possible Strategies to Fight Against the Antibiotic Resistance
    Md. Alamgir Hossain, Md. Kamrujjaman · 2023 · Asian Science Bulletin
  79. MYCOBACTERIUM TUBERCULOSIS HIP INFECTION MANAGEMENT: CASE REPORT AND LITERATURE REVIEW
    Mihnea-Ioan-Gabriel Popa, Adrian Cursaru, Alexandru Lupu · 2023 · Romanian Archives of Microbiology and Immunology
  80. A Case Report on Scrofuloderma: A Cutaneous Manifestation of Tuberculosis
    Soham R. Meghe, Adarshlata Singh, Drishti M Bhatt, Shreya N Gupta, Varun Hanumanthaiah, Sree Ramya Talasila · 2024 · Cureus
  81. Discordance in Genotypic and Phenotypic anti-tuberculosis drug susceptibility results: time to reconsider critical concentration
    Arti Shrivas, Sarman Singh, Jitendra Singh, Prem Shankar, Payal Soni, Syed Beenish Rufai, Anand Kumar Maurya, Shashank Purwar · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  82. Synthesis, Molecular Docking Study and Evaluation of Novel Nitroimidazole N-Arylacetamides Derivatives Against Mycobacterium Tuberculosis
    Nadim Chhipa, Pinkal H. Patel · 2024 · SSRN Electronic Journal
  83. Delays in Diagnosis and Treatment of Multi-Drug Resistant Tuberculosis: Magnitude and Institutional Barriers in Tanzania
    2024 · International Journal of Infectious Diseases and Research
  84. Combination therapies: Innovative strategies for enhancing treatment outcomes
    Nawal Hlal Almutairi, Nawal Ganai M Bahari, Alhanouf Zaid Almutairi, Mariam sabr shafagh alshameri, Hanadi Naji Alhajrasi, Faisal Nasser Alharbi, Manal Nasser Almasad, Noura Sultan Alotaibi, Bashayer Alshehri, Mashaal Nasser Almazroa et al. · 2023 · International Journal of Health Sciences
  85. Antimycobacterial compounds produced by endophytic fungi: An overview
    Yousra A. El‐Maradny, Teroj Abdulrahman Mohammed, Mina Maurice Samy Gerges · 2024 · Elsevier eBooks
  86. Tuberculosis in Brazil: Epidemiological aspects, diagnosis, and treatment
    Lucas Gabriel Quadros Ramos, Fernanda Moreira Soares Boaventura Silveira, Jessica Elen Martins Alves, Karina Andrade de Prince · 2024 · Seven Editora eBooks
  87. Exploring Knowledge Graphs (KG): A Comprehensive Overview
    Naima Syed, Shadab Alam Siddiqui, Hazra Imran · 2024 · Transactions on computer systems and networks
  88. Microbicidal Mechanisms for Light-Activated Molecular Nanomachines in Mycobacterium smegmatis : A Model for Pathogenic Bacteria
    Thushara Galbadage, Dongdong Liu, James M. Tour, Jeffrey D. Cirillo, Richard S. Gunasekera · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  89. Analysis of genetic characteristics associated with reduced bedaquiline susceptibility in multidrug-resistant Mycobacterium tuberculosis
    Shanshan Wang, Xiao Xiao, Shulan Dong, Jiayi Cao, Sainan Wang, Haiyan Xiong, Xuliang Li, Ge Shao, Yi Hu, Xin Shen · 2024 · Tuberculosis
  90. Chronic Infections and Coinfections
    Priti Devi, Rajesh Pandey · 2024 · Springer eBooks
  91. Temporal pattern and effect of COVID-19 on the trend of TB, DRTB, paediatrics TB and TB with HIV Coinfection: A decadal trend analysis
    Pushpendra Bairwa, Mahesh Chand Verma, Asha Kumari, Ajay Kumar Gupta, Yamini Singh · 2024 · Journal of Family Medicine and Primary Care
  92. Multidrugs Resistance: Concepts, Mechanisms, and Recent Advances
    Diptikanta Acharya, Sagarika Satapathy, Sandhyarani Patra, Goutam Jha, Somanath Sahoo, T. Gayatri · 2024 · Springer eBooks
  93. PPARγ mediated enhanced lipid biogenesis fuels Mycobacterium tuberculosis growth in a drug-tolerant hepatocyte environment
    Binayak Sarkar, Jyotsna Singh, Mohit Yadav, Priya Sharma, Raman Deep Sharma, Shweta Singh, Aakash Chandramouli, Kritee Mehdiratta, Ashwani Kumar, Siddhesh S. Kamat et al. · 2025 · eLife
  94. Pharmacokinetics of nanoparticles for infectious diseases
    Priyanka Dash, Jitu Halder, Tushar Kanti Rajwar, Deepak Pradhan, Chandan Das, Vineet Rai, Biswakanth Kar, Goutam Ghosh, Goutam Rath · 2025 · Elsevier eBooks
  95. Tuberculosis multirresistente en adolescente: A propósito de un caso
    Lorena García Agudelo, Julio César Velasco Castro, Mónica Liseth Holguín Barrera · 2025 · Infectio
  96. Rapid screening of primary and rationally synthesized anti-mycobacterial compounds in macrophage using double recombinant M. bovis BCG strain
    Mohd Mustkim Ansari, Rajendra Kumar Dhuriya, Gunjan, Ruchi Verma, Garima Kumari, Bhupendra Narain Singh · 2025 · Journal of Microbiological Methods
  97. Disseminated histoplasmosis and resistant tuberculosis in a patient with AIDS: A case report
    Luis Enrique Bermejo Galan, Dandara Melo Honorato, Stephanye Batista de Andrade, Manoel Messias Santos Neto, Artur Diogenes Pinheiro Paiva, Eloise T. M. Filardi, Marcela Romanazzi, Domingos Sávio Matos Dantas, Roberto Carlos Cruz Carbonell, Felipe A. Cerni et al. · 2025 · Medical Reports
  98. Stem cell-based therapies and organoid models: Advancing tuberculosis treatment and research
    Jiao-Mei Tang · 2025 · New cell
  99. Molecular Interactions of Mycobacterial Transporter for Novel Antimicrobial Strategies
    Arathi Radhakrishnan, Manisha Gurnani, Priyanka Gopi, Abhishek Pratap Singh Chauhan, Prateek Pandya, Raj Kishor Kapardar, Rajpal Srivastav · 2025 · Journal of Experimental Biology and Agricultural Sciences
  100. A complementary approach to measure construct validity of WHO QOL BREF in Indian multidrug-resistant tuberculosis (MDR-TB) patients through psychometric property and factor analysis
    Shweta Sharma, Arun Mahadeo Kokane, Subba N. Krishna, Ankur Joshi · 2025 · F1000Research